What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?

Archives of Dermatology

Volumn 146, Issue 8, 2010, Pages 903-905

  Lee, Kachiu C ^a   Risser, Jessica ^b,c   Bercovitch, Lionel ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CIMETIDINE; ETRETIN; ETRETINATE; IMIQUIMOD; INTERFERON; ISOTRETINOIN; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PODOPHYLLOTOXIN; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ADOLESCENT; ARTICLE; BOWEN DISEASE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHROMOSOME 17Q; CRYOTHERAPY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPOPIGMENTATION; LOW DRUG DOSE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; TINEA VERSICOLOR; TREATMENT DURATION; VIRUS LOAD; COMPLICATION; HIV INFECTIONS; PROCEDURES; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; AMINOQUINOLINES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EPIDERMODYSPLASIA VERRUCIFORMIS; HIV INFECTIONS; HUMANS; MALE; TREATMENT OUTCOME;

EID: 77955855308     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.194     Document Type: Article

References (19)

1. Lewandowsky F, Lutz W. Ein Fall einer bisher noch nicht beschriebener Hauterkrankung. Arch Derm Syphilol. 1922;141(2):193-202.
2. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32(4):579-581. (Pubitemid 35435168)
3. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis: genetic and virologic studies of a kindred. Arch Dermatol. 1985;121 (7):864-868. (Pubitemid 15070196)
4. Patel AS, Karagas MR, Pawlita M, Waterboer T, Nelson HH. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer. 2008;122(10):2377-2379. (Pubitemid 351542345)
5. de Oliveira WR, Festa Neto C, Rady PL, Tyring SK. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol. 2003;17(4):394-398.
6. Haas N, Fuchs PG, Hermes B, Henz BM. Remission of epidermodysplasia verruciformis- like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol. 2001;145(4):669-670. (Pubitemid 36138936)
7. Carré D, Dompmartin A, Verdon R, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol. 2003;42(4):296-300. (Pubitemid 36553228)
8. Rallis E, Paparizos V, Kyriakis K, Katsambas A. Treatment of epidermodysplasia verruciformis in human immunodeficiency virus-positive patients. J Eur Acad Dermatol Venereol. 2009;23(2):195-196.
9. Morrison C, Eliezri Y, Magro C, Nuovo GJ. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol. 2002; 29(8):480-489. (Pubitemid 35034459)
10. Berthelot C, Dickerson MC, Rady P, et al. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol. 2007;56(5):882-886. (Pubitemid 46561022)
11. Baskan EB, Tunali S, Adim SB, Turan A, Toker S. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge. J Dermatolog Treat. 2006;17(3):179-183. (Pubitemid 44147839)
12. Hu W, Nuovo G, Willen M, Somach S. Epidermodysplasia verruciformis in two half brothers with HIV infection. J Cutan Med Surg. 2004;8(5):357-360.
13. Anadolu R, Oskay T, Erdem C, Boyvat A, Terzi E, Gurgey E. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. J Am Acad Dermatol. 2001;45(2):296-299.
14. Gubinelli E, Posteraro P, Cocuroccia B, Girolomoni G. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. J Dermatolog Treat. 2003;14(3):184-188.
15. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol. 1984;83(1) (suppl):18s-25s.
16. Iraji F, Faghihi G. Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin. Clin Exp Dermatol. 2000;25 (1):41-43.
17. Al Rubaie S, Breuer J, Inshasi J, Al Saady S, Fathi I. Epidermodysplasia verruciformis with neurological manifestations. Int J Dermatol. 1998;37(10):766-771.
18. Rallis E, Papatheodorou G, Bimpakis E, Butanska D, Menounos P, Papadakis P. Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol. 2008;22(4):523-525.
19. de Oliveira WR, Neto CF, Rivitti EA. The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis. J Am Acad Dermatol. 2004;50 (6):e14-e15.